Biology of advanced uveal melanoma and next steps for clinical therapeutics. - Wikidata - awgldk - TriplyDB

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

http://www.wikidata.org/entity/Q35079709

about

Uveal melanoma as a target for immune-therapy Uveal Melanoma: Current Trends in Diagnosis and Management Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts.Ric-8A gene deletion or phorbol ester suppresses tumorigenesis in a mouse model of GNAQ(Q209L)-driven melanoma.Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.Verteporfin induces apoptosis and eliminates cancer stem-like cells in uveal melanoma in the absence of light activation In-depth proteomic profiling of the uveal melanoma secretome.Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.The biology of uveal melanoma Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.Presentation, Treatment, and Prognosis of Secondary Melanoma within the Orbit.Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma.Update on Metastatic Uveal Melanoma: Progress and Challenges.Assessing Prognosis in Uveal Melanoma.Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial.[Ocular melanomas : An update].Treatment of uveal melanoma: where are we now?Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations.GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome.

P2860

Q26747519-64D8B118-39DC-440B-85F4-8C8E03C28616 Q28073924-97C00A21-F777-4FC6-8841-5BF46B7D62AC Q35812275-BA7D353C-D403-45FA-92C3-47501D920B61 Q36264686-63375126-7C85-483D-8341-7A4B284E122E Q37096232-84F5865D-2A7B-443C-953E-1AD493525DEF Q37396884-A82E821B-BDD7-4BA8-8EA6-99B3E8B55826 Q37545095-23312DC4-A967-4C5A-A3D9-9C37B7C782F9 Q37580290-2478D327-E8F6-4C34-9E8C-8D2A212C2D50 Q37644842-619A44E1-52A2-4BCF-9C5D-B175640DFCAB Q37742632-C4FEECC6-46D1-4CE7-9B5D-9324C00C88F9 Q38646057-69EAA5A2-CBDD-412F-BC22-E0C887668F0B Q38687191-259D2D1F-8CCC-4E3A-A605-C09BB0246329 Q38718726-22BD9F9A-80B3-42ED-AA39-17E943CF7F5A Q38783505-66C4EF06-5427-4A2A-992E-6B2B7DD8D047 Q38842906-FCACE284-24A2-4FC7-BDDC-B2DE8CBA75DD Q41368436-C1260844-3DCE-49AB-99B7-490723F7697D Q42369030-705A74B5-21E6-47D1-B0D4-7C30186FC0F4 Q50077796-A11B125B-599D-4FCB-9072-C736E217E735 Q50349181-BAC697D2-62C6-4202-A761-8904EEE269A1 Q52774797-07698B30-22ED-401D-A63F-BEAF3CBFF22B Q54977580-65775475-08DF-47B6-84AF-E399B1D54B3A

P2860

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

http://www.wikidata.org/entity/Q35079709

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

@ast

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

@en

type

label

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

@ast

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

@en

prefLabel

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

@ast

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

@en

P1433

Q35079709-40EFDF0B-232D-4A62-BDC4-9A400DE73DD6

P1476

Q35079709-557DCC2D-16A2-4D12-A021-AF2982571316

P2093

Q35079709-323AE8A0-7E61-4BB9-AA30-67FCA915DEA8

Q35079709-4A947479-32A5-41A4-AB55-A601042A09CB

Q35079709-586BFA45-2BB3-4CD5-8642-60E4D4B0EF27

Q35079709-631A9D94-B65E-4849-9A93-85836656641D

Q35079709-7090625E-A493-4409-B021-0B752F668C28

Q35079709-9B6EA134-C0C0-40D7-B89F-A7DE030B8BCB

Q35079709-A8275445-EB34-4BF9-9B60-E75F4D1E7A4F

Q35079709-ABA0F7F2-4F31-4CD1-80CD-EDC93D5ACE96

Q35079709-BDF47A11-A95E-453B-BDB7-E76FFE7B010A

Q35079709-CAC8A25C-C0D8-42AC-BE9E-6B72DEBA85BE

P2860

Q35079709-07090190-C1B4-4082-8FAD-FEA870FE3008

Q35079709-082E12F2-7128-4EE4-9F23-2E1710C7C827

Q35079709-0CD793FA-8896-40DE-A139-4AADF38D99F4

Q35079709-0F792964-8DCA-4C18-9D34-B02194B27F61

Q35079709-153028B7-2CB9-4226-BF53-F90E33E8DA13

Q35079709-15DB3202-C95D-4804-A66D-3C174D71C1C0

Q35079709-182C3DA5-6EF0-43A3-B84D-E435E32DECED

Q35079709-19D6A27C-8237-4E0D-8058-90B8A2448381

Q35079709-19DAC62C-4411-498E-A11B-05CA2F625DDD

Q35079709-1B201AF0-909D-4398-A645-E56B9A75E665

P304

Q35079709-9820D62D-A3A3-4B15-8AD6-C2171EAF5917

P31

Q35079709-F87BF2A7-8E30-4521-A617-1C5A32B14655

P356

Q35079709-6CCA7FAF-E2C4-4253-8242-7D8C04CC912B

P433

Q35079709-2193A6CF-4EBF-4D37-8B80-400A1D3A18A7

P478

Q35079709-6B990D87-FFE6-4DB3-9841-CA0AE30B2AA3

P50

Q35079709-3E611EDB-1585-4C7B-9AEA-9EC6F304400D

Q35079709-901C7BAD-158C-45FD-8BC2-4BCFD0B26AB5

Q35079709-CFA35458-9C0D-490A-8701-C71CC0DBA2B7

Q35079709-EA9BAE3D-3FE6-482C-A002-4E8A8740150F

P577

Q35079709-925887ED-D863-4B4D-85AA-BF96691C7A83

P5875

Q35079709-0E663346-2E26-41DC-86FA-A70A7101955F

P698

Q35079709-6C2040B3-0E96-4547-9280-2A3EF94B3C3A

P932

Q35079709-A375A964-EFFB-4394-A412-D721C87304C4

P356

P1433

Pigment Cell & Melanoma Research

P1476

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

@en

P2093

Boris C Bastian

http://www.w3.org/2001/XMLSchema#string

Howard Z Streicher

http://www.w3.org/2001/XMLSchema#string

J Silvio Gutkind

http://www.w3.org/2001/XMLSchema#string

Jack Welch

http://www.w3.org/2001/XMLSchema#string

Jason J Luke

http://www.w3.org/2001/XMLSchema#string

Jeffery A Sossman

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Gershenwald

http://www.w3.org/2001/XMLSchema#string

Kyle C McKenna

http://www.w3.org/2001/XMLSchema#string

Magdalena Thurin

http://www.w3.org/2001/XMLSchema#string

Pierre L Triozzi

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha

Defining the human deubiquitinating enzyme interaction landscape

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

Germline mutations in BAP1 predispose to melanocytic tumors

Frequent mutation of BAP1 in metastasizing uveal melanomas

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma

Mutations in GNA11 in uveal melanoma

Germline BAP1 mutations predispose to malignant mesothelioma

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

Oncogenic mutations in GNAQ occur early in uveal melanoma

P304

135-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PCMR.12304

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Anne M. Bowcock

Erwin G Van Meir

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264675569

http://www.w3.org/2001/XMLSchema#string

P698

25113308

http://www.w3.org/2001/XMLSchema#string

P932

4326637

http://www.w3.org/2001/XMLSchema#string